| | |||||
| car | |||||
| 新闻 | |||||
| Junshi's COVID antiviral tops Pfizer's Paxlovid - Fierce Pharma Asia Johnson & Johnson and Legend Biotech further padded the case for their BCMA CAR-T therapy Carvykti in multiple myeloma.
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment